Company Search:
Advanced Search
Sponsored Links
BCAL Diagnostics Ltd Company Snapshot
BCAL Diagnostics Ltd operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares BCAL Diagnostics Ltd with three other pharmaceutical manufacturers in Australasia: Prescient Therapeutics Ltd (2021 sales of 66,285.00 Australian Dollars [US$48,312.49 ] of which 100% was Clinical stage oncology), Genetic Technologies Limited (120,554.00 Australian Dollars [US$87,866.99 ] ), and Auscann Group Holdings Ltd (232,675.00 Australian Dollars [US$169,587.50 ] of which 100% was Research and development of medicinal ca).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BCAL Diagnostics Ltd
  Stock Performance Chart for BCAL Diagnostics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/17/2021): .20
(Figures in Australian Dollars)
1 Week 2.6%   13 Weeks 25.8%  
4 Weeks n/a   52 Weeks n/a  
BCAL Diagnostics Ltd Key Data:
  Ticker: BDX Country: Australia
  Exchanges: ASX Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2021 Sales 275,252
(Year Ending Jan 2022).
Employees: N/A
  Currency: Australian Dollars Market Cap: 40,340,748
  Fiscal Yr Ends: June Shares Outstanding: 206,875,633
  Share Type: ORDINARY Closely Held Shares: 111,627,419
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.